Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Recurrent violence linked to substantially higher rates of mental disorders in post-conflict communities

  • Luck affects how we judge reckless actions

  • Motor skill deficiencies linked to autism severity, reseearch says

  • New ultrasound device may add in detecting risk for heart attack, stroke

  • Leaders call for expanded use of medications to combat opioid overdose epidemic

  • Take notes by hand for better long-term comprehension

  • Paying closer attention to attention

  • Small business owners not always worried about being treated fairly, researcher finds

  • Fruitfly study identifies brain circuit that drives daily cycles of rest, activity

  • New genetic brain disorder in humans discovered

  •